Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy

Retina

Volumn 21, Issue 6, 2001, Pages 647-651

  Oku, Hidehiro ^a   Kida, Teruyo ^a   Sugiyama, Tetsuya ^a   Hamada, Jun ^a   Sato, Bunpei ^a   Ikeda, Tsunehiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Endothelin 1; Nitric oxide; Proliferative diabetic retinopathy; Vitreous

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; VASOACTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLITE; PATHOGENESIS; RADIOIMMUNOASSAY; RETINA MACULA HOLE; VITREOUS BODY;

EID: 0035663678     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200112000-00013     Document Type: Article

References (37)

1. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery
2. Diabetes-induced vascular dysfunction in the retina: Role of endothelins
3. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
4. Immunohistochemical modification of vasoactive neuropeptides and excitatory amino acids in nervous tissue of Mongolian gerbil after transient cerebral ischemia
5. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
6. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1
7. Endothelin expression in ocular tissues of diabetic and insulin-treated rats
8. Elevated plasma endothelin in patients with diabetes mellitus
9. Increased plasma endothelin in NIDDM patients with retinopathy
10. Plasma endothelin-1 levels in non-insulin-dependent diabetes mellitus patients with macrovascular disease
11. Decreased plasma endothelin-1 levels in asymptomatic type I diabetic patients with regional cerebral hypoperfusion assessed by SPECT
12. Vascular endothelial cells synthesize nitric oxide from L-arginine
13. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
14. Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture
15. Induction and regulation of nitric oxide synthase in retinal Müller glial cells
16. Mechanism of nitric oxide-mediated neurotoxicity in primary brain
17. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase
18. L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients
19. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy
20. Endothelin-1-like immunoreactivity in human urine
21. 15N]nitrate in biological fluids
22. Induction of endothelin-1 expression by glucose: An effect of protein kinase C activation
23. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition
24. Immunoreactive endothelin levels in the vitreous fluid are decreased in diabetic patients with proliferative retinopathy
25. Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit
26. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits
27. Glutamate elevation in rabbit vitreous during transient ischemia-reperfusion
28. Elevated gammaaminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
29. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury
30. Relationships between the endothelin and nitric oxide pathways
31. L-arginine transport in retinas from streptozotocin diabetic rats: Correlation with the level of IL-1 beta and NO synthase activity
32. Direct demonstration of VEGF-induced nitric oxide production by choroidal endothelial cells
33. A redox based mechanism for neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds
34. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic goto-kakizaki rats: Correlation with blood-retinal barrier permeability
35. Ocular effects of the endothelins. Abundant peptides in the eye
36. Immunoreactive endothelin distribution in ocular tissues
37. Why are circulating concentrations of endothelin-1 so low?